Keros Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematological, pulmonary, and cardiovascular disorders. Their mission is to innovate therapies that have the potential to shift the treatment landscape in these areas.

MDS Foundation, Inc. Oct 10󰞋󰟠. 󰟝. We are looking for MDS patients to participate in the Keros Roundtable on October 12th and 18th.

Congratulations Keros Therapeutics, Inc. on your #IPO on. @Nasdaq . $KROS. Изображение. 4:47 ч. сл.об. · 8.04.2020 г.

Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for ...

Keros Pharmaceuticals, Inc.

Find contacts at this company